Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum
Hypertensive disorders of pregnancy (HDP) complicate approximately 10% of pregnancies. In addition to multiorgan manifestations related to endothelial dysfunction, HDP confers an increased risk of cardiovascular disease during delivery hospitalisation, such as heart failure, pulmonary oedema, acute...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-06-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2022.56 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846122337783513088 |
|---|---|
| author | Veronica Giorgione Matthew Cauldwell Basky Thilaganathan |
| author_facet | Veronica Giorgione Matthew Cauldwell Basky Thilaganathan |
| author_sort | Veronica Giorgione |
| collection | DOAJ |
| description | Hypertensive disorders of pregnancy (HDP) complicate approximately 10% of pregnancies. In addition to multiorgan manifestations related to endothelial dysfunction, HDP confers an increased risk of cardiovascular disease during delivery hospitalisation, such as heart failure, pulmonary oedema, acute MI and cerebrovascular events. However, the cardiovascular legacy of HDP extends beyond birth since these women are significantly more likely to develop cardiovascular risk factors in the immediate postnatal period and major cardiovascular disease in the long term. The main mediator of cardiovascular disease in women with a history of HDP is chronic hypertension, followed by obesity, hypercholesterolaemia and diabetes. Therefore, optimising blood pressure levels from the immediate postpartum period until the first months postnatally could have beneficial effects on the development of hypertension and improve long-term cardiovascular health. Peripartum screening based on maternal demographic, and clinical and echocardiographic data could help clinicians identify women with HDP at highest risk of developing postpartum hypertension who would benefit from targeted primary cardiovascular prevention. |
| format | Article |
| id | doaj-art-93e2e8edc13c46dead4aee572c0cd4a5 |
| institution | Kabale University |
| issn | 1758-3756 1758-3764 |
| language | English |
| publishDate | 2023-06-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | European Cardiology Review |
| spelling | doaj-art-93e2e8edc13c46dead4aee572c0cd4a52024-12-14T16:04:28ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642023-06-011810.15420/ecr.2022.56Pre-eclampsia and Cardiovascular Disease: From Pregnancy to PostpartumVeronica Giorgione0Matthew Cauldwell1Basky Thilaganathan2Molecular and Clinical Sciences Research Institute, St. George’s University of London, London, UK; Department of Obstetrics and Gynaecology, St George’s University Hospitals NHS Foundation Trust, London, UKDepartment of Obstetrics and Gynaecology, St George’s University Hospitals NHS Foundation Trust, London, UKMolecular and Clinical Sciences Research Institute, St. George’s University of London, London, UK; Department of Obstetrics and Gynaecology, St George’s University Hospitals NHS Foundation Trust, London, UKHypertensive disorders of pregnancy (HDP) complicate approximately 10% of pregnancies. In addition to multiorgan manifestations related to endothelial dysfunction, HDP confers an increased risk of cardiovascular disease during delivery hospitalisation, such as heart failure, pulmonary oedema, acute MI and cerebrovascular events. However, the cardiovascular legacy of HDP extends beyond birth since these women are significantly more likely to develop cardiovascular risk factors in the immediate postnatal period and major cardiovascular disease in the long term. The main mediator of cardiovascular disease in women with a history of HDP is chronic hypertension, followed by obesity, hypercholesterolaemia and diabetes. Therefore, optimising blood pressure levels from the immediate postpartum period until the first months postnatally could have beneficial effects on the development of hypertension and improve long-term cardiovascular health. Peripartum screening based on maternal demographic, and clinical and echocardiographic data could help clinicians identify women with HDP at highest risk of developing postpartum hypertension who would benefit from targeted primary cardiovascular prevention.https://www.ecrjournal.com/articleindex/ecr.2022.56 |
| spellingShingle | Veronica Giorgione Matthew Cauldwell Basky Thilaganathan Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum European Cardiology Review |
| title | Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum |
| title_full | Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum |
| title_fullStr | Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum |
| title_full_unstemmed | Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum |
| title_short | Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum |
| title_sort | pre eclampsia and cardiovascular disease from pregnancy to postpartum |
| url | https://www.ecrjournal.com/articleindex/ecr.2022.56 |
| work_keys_str_mv | AT veronicagiorgione preeclampsiaandcardiovasculardiseasefrompregnancytopostpartum AT matthewcauldwell preeclampsiaandcardiovasculardiseasefrompregnancytopostpartum AT baskythilaganathan preeclampsiaandcardiovasculardiseasefrompregnancytopostpartum |